Standout Papers
- Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase (2005)
- DNA repair pathways as targets for cancer therapy (2008)
- Hydroxyurea-Stalled Replication Forks Become Progressively Inactivated and Require Two Different RAD51-Mediated Pathways for Restart and Repair (2010)
- The underlying mechanism for the PARP and BRCA synthetic lethality: Clearing up the misunderstandings (2011)
- Mechanisms underlying mutational signatures in human cancers (2014)
- The cell-cycle checkpoint kinase Chk1 is required for mammalian homologous recombination repair (2005)
Immediate Impact
8 by Nobel laureates 51 from Science/Nature 168 standout
Citing Papers
Transcription–replication conflicts underlie sensitivity to PARP inhibitors
2024 StandoutNature
RHOJ controls EMT-associated resistance to chemotherapy
2023 StandoutNature
Works of Thomas Helleday being referenced
Chk1 promotes replication fork progression by controlling replication initiation
2010
Hydroxyurea-Stalled Replication Forks Become Progressively Inactivated and Require Two Different RAD51-Mediated Pathways for Restart and Repair
2010 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Thomas Helleday | 17550 | 9992 | 3950 | 262 | 21.6k | |
| Shunichi Takeda | 16317 | 6889 | 3490 | 299 | 20.5k | |
| André Nussenzweig | 18815 | 6792 | 3585 | 160 | 21.8k | |
| Yosef Shiloh | 20836 | 9483 | 5762 | 204 | 23.8k | |
| Eric W.‐F. Lam | 15136 | 5354 | 3995 | 297 | 22.8k | |
| Andrew L. Kung | 16386 | 6498 | 4559 | 282 | 23.8k | |
| Penny A. Jeggo | 18359 | 6910 | 5055 | 187 | 21.5k | |
| Andres J. Klein–Szanto | 11861 | 6907 | 4799 | 380 | 20.9k | |
| Allan Balmain | 12359 | 7727 | 3923 | 203 | 18.1k | |
| Christopher J. Lord | 16571 | 14756 | 3997 | 192 | 23.8k | |
| Nicola J. Curtin | 11765 | 10662 | 1888 | 195 | 16.4k |
All Works
Login with ORCID to disown or claim papers
Loading papers...